337 related articles for article (PubMed ID: 28541665)
1. Identification of Small Molecule Translesion Synthesis Inhibitors That Target the Rev1-CT/RIR Protein-Protein Interaction.
Sail V; Rizzo AA; Chatterjee N; Dash RC; Ozen Z; Walker GC; Korzhnev DM; Hadden MK
ACS Chem Biol; 2017 Jul; 12(7):1903-1912. PubMed ID: 28541665
[TBL] [Abstract][Full Text] [Related]
2. Interaction between the Rev1 C-Terminal Domain and the PolD3 Subunit of Polζ Suggests a Mechanism of Polymerase Exchange upon Rev1/Polζ-Dependent Translesion Synthesis.
Pustovalova Y; Magalhães MT; D'Souza S; Rizzo AA; Korza G; Walker GC; Korzhnev DM
Biochemistry; 2016 Apr; 55(13):2043-53. PubMed ID: 26982350
[TBL] [Abstract][Full Text] [Related]
3. Structural Approach To Identify a Lead Scaffold That Targets the Translesion Synthesis Polymerase Rev1.
Dash RC; Ozen Z; Rizzo AA; Lim S; Korzhnev DM; Hadden MK
J Chem Inf Model; 2018 Nov; 58(11):2266-2277. PubMed ID: 30289707
[TBL] [Abstract][Full Text] [Related]
4. Virtual Pharmacophore Screening Identifies Small-Molecule Inhibitors of the Rev1-CT/RIR Protein-Protein Interaction.
Dash RC; Ozen Z; McCarthy KR; Chatterjee N; Harris CA; Rizzo AA; Walker GC; Korzhnev DM; Hadden MK
ChemMedChem; 2019 Sep; 14(17):1610-1617. PubMed ID: 31361935
[TBL] [Abstract][Full Text] [Related]
5. Lead compound profiling for small molecule inhibitors of the REV1-CT/RIR Translesion synthesis Protein-Protein interaction.
Zaino AM; Dash RC; James SJ; MacGilvary N; Crompton A; McPherson KS; Stanzione M; Korzhnev DM; Dyson NJ; Chatterjee N; Cantor SB; Hadden MK
Bioorg Med Chem; 2024 May; 106():117755. PubMed ID: 38749343
[TBL] [Abstract][Full Text] [Related]
6. Small molecule scaffolds that disrupt the Rev1-CT/RIR protein-protein interaction.
Ozen Z; Dash RC; McCarthy KR; Chow SA; Rizzo AA; Korzhnev DM; Hadden MK
Bioorg Med Chem; 2018 Aug; 26(14):4301-4309. PubMed ID: 30037752
[TBL] [Abstract][Full Text] [Related]
7. NMR structure and dynamics of the C-terminal domain from human Rev1 and its complex with Rev1 interacting region of DNA polymerase η.
Pozhidaeva A; Pustovalova Y; D'Souza S; Bezsonova I; Walker GC; Korzhnev DM
Biochemistry; 2012 Jul; 51(27):5506-20. PubMed ID: 22691049
[TBL] [Abstract][Full Text] [Related]
8. The vital role of polymerase ζ and REV1 in mutagenic, but not correct, DNA synthesis across benzo[a]pyrene-dG and recruitment of polymerase ζ by REV1 to replication-stalled site.
Hashimoto K; Cho Y; Yang IY; Akagi J; Ohashi E; Tateishi S; de Wind N; Hanaoka F; Ohmori H; Moriya M
J Biol Chem; 2012 Mar; 287(12):9613-22. PubMed ID: 22303021
[TBL] [Abstract][Full Text] [Related]
9. Rev1 promotes replication through UV lesions in conjunction with DNA polymerases η, ι, and κ but not DNA polymerase ζ.
Yoon JH; Park J; Conde J; Wakamiya M; Prakash L; Prakash S
Genes Dev; 2015 Dec; 29(24):2588-602. PubMed ID: 26680302
[TBL] [Abstract][Full Text] [Related]
10. The Proliferating Cell Nuclear Antigen (PCNA)-interacting Protein (PIP) Motif of DNA Polymerase η Mediates Its Interaction with the C-terminal Domain of Rev1.
Boehm EM; Powers KT; Kondratick CM; Spies M; Houtman JC; Washington MT
J Biol Chem; 2016 Apr; 291(16):8735-44. PubMed ID: 26903512
[TBL] [Abstract][Full Text] [Related]
11. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
Pustovalova Y; Maciejewski MW; Korzhnev DM
J Mol Biol; 2013 Sep; 425(17):3091-105. PubMed ID: 23747975
[TBL] [Abstract][Full Text] [Related]
12. The non-canonical protein binding site at the monomer-monomer interface of yeast proliferating cell nuclear antigen (PCNA) regulates the Rev1-PCNA interaction and Polζ/Rev1-dependent translesion DNA synthesis.
Sharma NM; Kochenova OV; Shcherbakova PV
J Biol Chem; 2011 Sep; 286(38):33557-66. PubMed ID: 21799021
[TBL] [Abstract][Full Text] [Related]
13. Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links.
Hicks JK; Chute CL; Paulsen MT; Ragland RL; Howlett NG; Guéranger Q; Glover TW; Canman CE
Mol Cell Biol; 2010 Mar; 30(5):1217-30. PubMed ID: 20028736
[TBL] [Abstract][Full Text] [Related]
14. Structure-Based Drug Design of Phenazopyridine Derivatives as Inhibitors of Rev1 Interactions in Translesion Synthesis.
McPherson KS; Zaino AM; Dash RC; Rizzo AA; Li Y; Hao B; Bezsonova I; Hadden MK; Korzhnev DM
ChemMedChem; 2021 Apr; 16(7):1126-1132. PubMed ID: 33314657
[TBL] [Abstract][Full Text] [Related]
15. REV1-Polζ maintains the viability of homologous recombination-deficient cancer cells through mutagenic repair of PRIMPOL-dependent ssDNA gaps.
Taglialatela A; Leuzzi G; Sannino V; Cuella-Martin R; Huang JW; Wu-Baer F; Baer R; Costanzo V; Ciccia A
Mol Cell; 2021 Oct; 81(19):4008-4025.e7. PubMed ID: 34508659
[TBL] [Abstract][Full Text] [Related]
16. Interaction with DNA polymerase eta is required for nuclear accumulation of REV1 and suppression of spontaneous mutations in human cells.
Akagi J; Masutani C; Kataoka Y; Kan T; Ohashi E; Mori T; Ohmori H; Hanaoka F
DNA Repair (Amst); 2009 May; 8(5):585-99. PubMed ID: 19157994
[TBL] [Abstract][Full Text] [Related]
17. A stapled POL κ peptide targets REV1 to inhibit mutagenic translesion synthesis.
Chatterjee N; D'Souza S; Shabab M; Harris CA; Hilinski GJ; Verdine GL; Walker GC
Environ Mol Mutagen; 2020 Oct; 61(8):830-836. PubMed ID: 32573829
[TBL] [Abstract][Full Text] [Related]
18. Implications of inhibition of Rev1 interaction with Y family DNA polymerases for cisplatin chemotherapy.
Yoon JH; Johnson RE; Prakash L; Prakash S
Genes Dev; 2021 Sep; 35(17-18):1256-1270. PubMed ID: 34385260
[TBL] [Abstract][Full Text] [Related]
19. Multifaceted recognition of vertebrate Rev1 by translesion polymerases ζ and κ.
Wojtaszek J; Liu J; D'Souza S; Wang S; Xue Y; Walker GC; Zhou P
J Biol Chem; 2012 Jul; 287(31):26400-8. PubMed ID: 22700975
[TBL] [Abstract][Full Text] [Related]
20. A Small Molecule Targeting Mutagenic Translesion Synthesis Improves Chemotherapy.
Wojtaszek JL; Chatterjee N; Najeeb J; Ramos A; Lee M; Bian K; Xue JY; Fenton BA; Park H; Li D; Hemann MT; Hong J; Walker GC; Zhou P
Cell; 2019 Jun; 178(1):152-159.e11. PubMed ID: 31178121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
